hyperplasia of prostate	is a	benign prostatic condition
hyperplasia of prostate	causes	lower urinary tract symptoms
hyperplasia of prostate	causes	urinary retention
hyperplasia of prostate	causes	nocturia
hyperplasia of prostate	causes	urinary hesitancy
hyperplasia of prostate	causes	weak urinary stream
hyperplasia of prostate	causes	urgency
hyperplasia of prostate	causes	frequency
hyperplasia of prostate	leads to	bladder outlet obstruction
bladder outlet obstruction	leads to	detrusor hypertrophy
detrusor hypertrophy	may cause	urge incontinence
hyperplasia of prostate	predisposes to	urinary tract infection
hyperplasia of prostate	predisposes to	hydronephrosis
age	is a risk factor for	hyperplasia of prostate
family history	is associated with	hyperplasia of prostate
obesity	associated with	hyperplasia of prostate
digital rectal examination	is used for	assessment of hyperplasia of prostate
PSA	is not specific for	hyperplasia of prostate
transrectal ultrasound	is used for	evaluation of hyperplasia of prostate
urodynamic testing	helps	evaluate obstruction in hyperplasia
urine flow rate	indicates	obstruction severity
post-void residual	correlates with	obstruction severity
urinalysis	can show	infection or inflammation
urinary tract infection	risk factors include	urinary retention
hydronephrosis	may result from	urinary obstruction
renal function	may decline with	chronic obstruction
catheterization	provides	relief of urinary retention
urinary catheter	is used for	drainage in urinary retention
self-catheterization	used for	chronic urinary retention
transurethral resection of the prostate	is a	surgical treatment for hyperplasia of prostate
transurethral resection of the prostate	relieves	urinary obstruction
open prostatectomy	is a	surgical treatment for large prostates
laser enucleation of the prostate	is a	surgical treatment for hyperplasia of prostate
greenlight laser therapy	is a	surgical treatment for hyperplasia of prostate
TURP	is a	surgical procedure for hyperplasia of prostate
TURP	relieves	urinary obstruction
5-alpha-reductase inhibitors	reduce	prostate volume
finasteride	is a	5-alpha-reductase inhibitor
dutasteride	is a	5-alpha-reductase inhibitor
5-alpha-reductase inhibitors	reduce	dihydrotestosterone
alpha-1 blockers	improve	urinary flow
tamsulosin	is a	alpha-1 blocker
terazosin	is a	alpha-1 blocker
watchful waiting	is a	management option for mild hyperplasia of prostate
observation	is a	management option for mild hyperplasia of prostate
antimuscarinic agents	treat	overactive bladder symptoms associated with hyperplasia of prostate
urinary retention	increases risk of	bladder overdistension
bladder overdistension	leads to	detrusor dysfunction
detrusor dysfunction	causes	voiding dysfunction
age	correlates with	prostate size
prostate size	correlates with	symptom severity
prostate volume	increases with	age
prostate enlargement	associated with	obstruction
prostate enlargement	compresses	urethra
urethra	narrows due to	prostate enlargement
urinary symptoms	impact	quality of life
quality of life	worsens with	urinary retention
urine flow rate	improves with	alpha-1 blockers
post-void residual	reduces with	TURP
post-void residual	reduces with	finasteride
prostate-specific antigen	can be elevated with	prostate diseases
PSA	used in	prostate cancer screening
prostate cancer	must be ruled out in	evaluation of hyperplasia of prostate
family history	increases risk for	prostate enlargement
age	increases likelihood of	surgery for hyperplasia of prostate
obstruction	worsens	urinary symptoms
urinary retention	treated with	catheterization
urinary retention	may require	permanent catheter
hydronephrosis	may accompany	urinary obstruction
bladder wall thickening	results from	chronic obstruction
detrusor overactivity	contributes to	urge incontinence
urinary incontinence	occurs with	hyperplasia of prostate
nocturia	is a symptom of	hyperplasia of prostate
urinary frequency	is a symptom of	hyperplasia of prostate
urinary urgency	is a symptom of	hyperplasia of prostate
urinary hesitancy	is a symptom of	hyperplasia of prostate
urinary retention	is a complication of	hyperplasia of prostate
urinary stasis	promotes	stone formation
stone formation	occurs with	urinary obstruction
urinary tract infection	may complicate	urinary retention
antibiotics	treat	urinary tract infection
bladder detrusor	may hypertrophy in	chronic obstruction
renal perfusion	may be affected by	chronic obstruction
nephropathy	risk increases with	hydronephrosis
uroflowmetry	assesses	urine flow rate
urodynamic study	evaluates	obstruction in hyperplasia of prostate
prostate gland	enlarges with	age
age	correlates with	prostate enlargement
prostate enlargement	often presents with	LUTS
LUTS	include	nocturia
LUTS	include	urinary frequency
LUTS	include	urgency
LUTS	include	dysuria
urinary symptoms	varying	severity across patients
symptom severity	guides	treatment choice
mild hyperplasia of prostate	managed with	observation
moderate hyperplasia of prostate	managed with	medical therapy
severe hyperplasia of prostate	managed with	surgical therapy
surgical therapy	reduces	obstruction
medical therapy	aims to	relieve symptoms
antibiotics	not routinely used for	hyperplasia of prostate
 PSA test	not definitive for	distinguishing BPH from cancer
